Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer.
Li Y, Pan C, Gao Y, Zhang L, Ji D, Cui X, Zhang X, Cai Y, Zhang Y, Yao Y, Wang L, Leng J, Zhan T, Wu D, Gao Z, Sun YS, Li Z, Luo H, Wu A.
Li Y, et al. Among authors: zhang l, zhang x, zhang y.
JAMA Surg. 2024 May 1;159(5):529-537. doi: 10.1001/jamasurg.2023.7996.
JAMA Surg. 2024.
PMID: 38381429
Clinical Trial.